Myomo® Announces Participation in Beijing Trade Show
CAMBRIDGE, Mass., and BEIJING, China, May 23, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announces its participation in the China International Fair for Trade in Services, to be held in Beijing from […]
Myomo Reports First Quarter 2019 Results
CAMBRIDGE, Mass., May 13, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced its financial results for the first quarter ended March 31, 2019. Read more.
Myomo to Report First Quarter 2019 Results on May 13, 2019
CAMBRIDGE, Mass., May 7, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the first quarter ended March 31, 2019 on Monday, May 13, […]
Myomo® Announces New Distribution Agreement for Australia / New Zealand
CAMBRIDGE, Mass., May 1, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with NeuroMuscular Orthotics Pty Ltd (NMO) with the goal of offering MyoPro across […]
Myomo® Announces New Sales and Service Agreement for Chile
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with Tecnoplanta Orthopedic Laboratory with the goal of offering MyoPro in Chile. Read more.
Myomo® Announces New Sales and Service Agreement for Italy
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with Progettiamo Autonomia Robotics (PAR) with the goal of offering MyoPro in Italy. PAR is a unit of […]
Myomo Makes NYSE American Section 610(b) Public Announcement
CAMBRIDGE, Mass., March 15, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2018 filed […]
Kessler Foundation Awarded Grant to Study Wearable Robotic in Spinal Cord Injury
East Hanover, NJ – March 12, 2018 – Ghaith J. Androwis, PhD, research scientist in the Center for Mobility and Engineering Rehabilitation Research at Kessler Foundation, has been awarded a $500,000 grant from the Department of Defense (DOD), Congressionally Directed Medical Research Programs (CDMRP). The award funds a three-year study titled, “Efficacy of Wearable Robotic […]
Myomo Announces Participation at Two Upcoming Investor Conferences
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that Chairman and Chief Executive Officer Paul R. Gudonis and Chief Financial Officer David Henry will be presenting, as well as meeting […]
Myomo Reports Fourth Quarter and Year End 2018 Results
CAMBRIDGE, Mass., March 7, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced its financial results for the fourth quarter and year ended December 31, 2018. Read more.